Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-488-3 | CAS number: 1471311-93-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50(oral) = 4752 mg/kg bw. (BASF, 1981)
LD50(dermal) > 2000 mg/kg bw (Bioassay, 2013)
LC0(inhalation) = 0.11 mg/L (BASF, 1981); no mortalilty occured at this dose level.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Acute oral toxicity:
The test substance was tested in an acute oral toxicity study comparable to OECD guideline 401 (BASF, 1981). The test substance was applied to five male and five female Sprague-Dawley rats per dose group at doses of 2150, 3160, 5000, 6810 and 10000 mg/kg bw. The animals were observed for 14 days and animals were observed daily for clinical signs and mortality. Weighing was performed on day 0, day 2-4, day 7 and day 13. After 14 days, the surviving animals were subjected to a gross pathological examination. Animals that died were examined as quickly as possible. The following mortalities were observed: 2150 mg/kg: no deaths; 3160 mg/kg: 2/5 males and 0/5 females died; 5000 mg/kg: 2/5 males and 2/5 females died; 6810 mg/kg: 5/5 males and 4/5 females died; 10000 mg/kg: all animals died. Observed clinical signs included: dyspnea, stertor, apathy, abnormal position, staggering, paresis (hind leg), spastic gait, piloerection, erythema, exsiccosis, exophthalamus, salivation, blood (in the nose and/or in the urine), poor general state. Not all clinical signs were observed in all dose groups. The surviving animals gained weight as expected. Upon gross pathological examination the following findings were made in animals that died: Heart: acute atrial dilatation; acute congestive hyperemia; stomach: diffuse reddening of true stomach; intestines: atonic, mucosal reddening, diarrhea and hematinic contents. Nothing unusual was observed in animals that were sacrificed at the end of the observation period. An oral LD50 (males and females) was calculated to be 4752 mg/kg bw.
Acute inhalation:
In a standardized inhalation hazard test with a saturated vapour atmosphere, 0/12 rats died after 7 h exposure (BASF, 1981). The test was performed in principle as described in OECD test guideline 403. It demonstrates the toxicity of an atmosphere saturated with vapors of the volatile components of a test substance at 20 °C. Young adult laboratory rats, 6 per sex, were exposed sequentially to the vapors generated by bubbling 200 L/h air through a substance column of about 5 cm above a fritted glass disc in a glass cylinder for 7 h. The exposure was subsequently repeated in the same manner. No analytical determination of the atmosphere concentrations was performed. The nominal concentration was calculated as quotient of the amount of test substance weight loss during exposure, and the amount of air used during exposure.The LC0 is 0.11 mg/l air for male and female rats. No clinical signs and no signs of local respiratory irritation were observed. All animals gained weight as expected and no mortalities occured. Necropsy was inconspicuous.
Acute dermal toxicity:
In an acute dermal toxicity study (Limit Test, according to OECD 402 and GLP), young adult Wistar rats (5 males and 5 females)were dermally exposed to a single dose of 2000 mg/kg bw of the undiluted Korantin MAT to the clipped skin (dorsal and dorso-lateral parts of the trunk) and covered by semi- occlusive dressing for 24 hours (Bioassay, 2013). The application area comprised at least 10% of the total body surface area. The animals were observed for 14 days.
The following test item-related clinical signs and local effects were recorded during the course of the study:
- No mortality occurred
- No signs of systemic toxicity
- Very slight to well-defined erythema (grade 1 to 2)
- The mean body weight of the male animals increased within the
normal range throughout the study period. The mean body weight of the
female animals did not adequately increase during the first
post-exposure observation week, probably due to the bandage procedure,
but increased during the second week within the normal range.
- No macroscopic pathologic abnormalities were noted in the animals
examined at the end of the study.
Accordingly, the acute dermal median lethal dose (LD50) in the rat was
determined to be > 2000 mg/kg bw.
Justification for classification or non-classification
Based on the available acute toxicity studies, the substance was neither classified according to Directive 67/548/EEC nor according to CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.